12:00 AM
 | 
Apr 15, 2013
 |  BC Week In Review  |  Company News  |  Other News

StemCells, California Institute for Regenerative Medicine neurology news

StemCells announced details of a September 2012, 10-year, $19.3 million forgivable loan being provided by CIRM for the biotech to evaluate its HuCNS-SC purified human neural stem cells to treat Alzheimer's disease. The goal of the funding is to submit an IND with FDA. StemCells said it is...

Read the full 218 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >